First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain
Conditions
- Progressive Supranuclear Palsy (PSP)
- Healthy Participants
Interventions
- DRUG: [18F]ABBV-964i
- DRUG: [18F]ABBV-965i
- DRUG: Lead Candidate
Sponsor
Invicro
Collaborators